| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 139 |
| September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 3 | 2 | 1 | 1 | 3 | 5 | 2 |
| Views | |
|---|---|
| SCOPUS19337213-2016-13-4-SID84975221908-a1.pdf | 21 |
| Views | |
|---|---|
| Russia | 83 |
| Views | |
|---|---|
| Kazan | 83 |